|

Home Country Bias: If You’re Not Convinced Yet, Look at This

The Dow Jones Industrial Average is as American as apple pie.

For most U.S. investors, the 30 American companies that comprise “the Dow” are the natural starting point of building a portfolio of stocks.

Names like Wal-Mart (WMT)… Disney (DIS)… McDonald’s (MCD)… Caterpillar (CAT)… and Apple (AAPL).

They feel as familiar to U.S. investors as, well, apple pie feels to an Oklahoman at the county fair.

And since familiarity naturally leads to increased comfort and confidence, U.S. investors routinely over-allocate to U.S. stocks – including many of the household names in the Dow.

But as I explained in March (links in the P.S.), truly successful investors resist the urge to feel comfortable in their stock selections. Instead of seeking comfort, the best investors seek markets that show the best chance of outperforming.

And often, outperformance requires looking outside the United States.

That’s certainly been the case this year, as my Cycle 9 Alert subscribers can attest, and as you’ll see in the chart below.

Everyone on CNBC was celebrating the Dow’s crossing of 22,000 last week. But they neglected to tell you how foreign stock markets have been a far better bet.

I warned back in March that we’d likely see this happen, and I counseled against lazily falling victim to the so-called home country bias.

Stock markets have continued to march higher since then…

The Dow Jones Industrial Average is up a further 5.6%.

But foreign markets have continued to outpace U.S. stocks.

Germany gained 8%… and is now up 16.1% year to date.

Chinese stocks climbed 8.6%… now up 21.5% year to date.

Spanish stocks rose nearly 14%… putting their year-to-date gains at 26.5%.

And Mexican stocks climbed a further 15%… putting them in the #1 spot, up 30% year to date!

Here’s that chart, summarizing the year-to-date returns of the world’s Top 15 economies:

As you can see, most foreign markets have fared better than the Dow in 2017.

Chinese stocks have provided double the return.

Mexican stocks have nearly tripled it!

Who would have predicted this?!

Look, I get it… investing in foreign stock markets feels riskier than investing in the All-American names.

Author

More from Dent Research Team of Analysts
Share:

Editor's Picks

EUR/USD remains offered below 1.1800, looks at US data

EUR/USD is still trading on the defensive in the latter part of Thursday’s session, while the US Dollar maintains its bid bias as investors now gear up for Friday’s key release of the PCE data, advanced Q4 GDP prints and flash PMIs.
 

GBP/USD bounces off monthly lows near 1.3430

GBP/USD is sliding in tandem with its risk-sensitive peers, drifting back towards the 1.3430 area, its lowest levels in the month. The move reflects a firmer Greenback, supported by another round of solid US data and a somewhat divided FOMC Minutes.

Gold surrenders some gains, back below $5,000

Gold is giving away part of its earlier gains on Thursday, receding to the sub-$5,000 region per troy ounce. The precious metal is finding support from renewed geopolitical tensions in the Middle East and declining US Treasury yields across the curve in a context of further advance in the Greenback.

XRP edges lower as SG-FORGE integrates EUR stablecoin on XRP Ledger

Ripple’s (XRP) outlook remains weak, as headwinds spark declines toward the $1.40 psychological support at the time of writing on Thursday.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.